NASDAQ$VANI
Vivani Medical, Inc · Q3 2025 earnings
Q3 2025 earnings · · Before market open
Briefing
Vivani Medical reported Q3 2025, net loss of $6.5M.
For Q3 2025, Vivani Medical reported a net loss of $6.5M. Management discusses segment performance, capital allocation, and macro risks in the quarterly filing.
- Net loss $6.5M.
- Vivani Medical MD&A covers liquidity, credit, and operating priorities.
- Vivani Medical MD&A covers liquidity, credit, and operating priorities.
Headline financials
Revenue & EPS history
Vivani Medical, Inc · Revenue · Quarterly
$0
Forward guidance
The quarterly filing discusses operating priorities, capital returns, and sector risks.
Tailwinds
- MD&A highlights liquidity, capital, and core business trends.
- Segment commentary supports the earnings narrative.
Headwinds
- Macro, rates, or input costs may pressure near-term margins.
- One-time items can affect year-over-year comparability.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q3 2025
+0.6%
Avg return
Earnings day
-0.4%
Avg return
5 days after
+1.5%
Avg return
30 days after
52%
13 / 25 earnings
Positive
+27.6%
Q1 2021
Best reaction
-11.4%
Q3 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q4 2026 | +1.8% | -0.9% | -3.5% | |
| Q3 2025 | -11.4% | -7.8% | -11.8% | |
| Q2 2025 | -0.8% | -2.4% | -4.7% | |
| Q1 2025 | +1.9% | +0.0% | +15.5% | |
| Q3 2024 | +11.2% | +5.6% | +4.8% | |
| Q2 2024 | +0.0% | +10.3% | +6.9% | |
| Q4 2022 | +2.1% | -8.4% | +13.4% | |
| Q1 2022 | +0.7% | +36.1% | +45.6% | |
| Q3 2021 | +1.5% | -3.7% | -28.7% | |
| Q2 2021 | -5.0% | -9.7% | -6.3% | |
| Q1 2021 | +27.6% | -1.2% | +33.0% | |
| Q3 2020 | +1.3% | +4.6% | +78.5% | |
| Q2 2020 | +3.4% | +17.8% | -14.8% | |
| Q1 2020 | -4.0% | -1.0% | -11.0% | |
| Q3 2019 | -5.3% | -8.5% | -15.5% | |
| Q2 2019 | +0.4% | +7.6% | +4.9% | |
| Q1 2019 | -7.5% | -17.6% | -31.9% | |
| Q3 2018 | -4.7% | -14.1% | -37.6% | |
| Q2 2018 | +1.8% | -1.8% | +6.7% | |
| Q1 2018 | +1.5% | +10.8% | -8.2% | |
| Q3 2017 | +0.0% | +3.5% | +31.3% | |
| Q2 2017 | -6.6% | -20.3% | -7.4% | |
| Q1 2017 | +0.0% | -0.9% | -2.6% | |
| Q3 2016 | -1.5% | -4.5% | -4.5% | |
| Q2 2016 | +5.3% | -3.0% | -15.7% | |
| Q1 2016 | — | — | — | |
| Q3 2015 | — | — | — | |
| Q2 2015 | — | — | — | |
| Q1 2015 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro